Invention Grant
- Patent Title: Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
-
Application No.: US16805315Application Date: 2020-02-28
-
Publication No.: US11667918B2Publication Date: 2023-06-06
- Inventor: Bob D. Brown , Henryk T. Dudek
- Applicant: Dicerna Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Dicerna Pharmaceuticals, Inc.
- Current Assignee: Dicerna Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Dechert LLP
- Agent Andrea L.C. Reid; Gang Wang
- The original application number of the division: US15572663
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07H21/02 ; A61P7/00 ; C07H21/04
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing AT3 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Public/Granted literature
- US20210095279A1 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ANTITHROMBIN 3 (AT3) BY DOUBLE-STRANDED RNA Public/Granted day:2021-04-01
Information query
IPC分类:
